Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Human Papillomavirus-positive Oropharyngeal Cancer - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Human Papillomavirus-positive Oropharyngeal ... Read More
-
NK Cell therapies - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage NK ... Read More
-
ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
... Mutated Metastatic Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The ESR1 Mutated Metastatic Breast Cancer market report provides current treatment practices, emerging drugs, ESR1 ... Read More
-
Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
Advanced Urothelial Carcinoma - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Advanced Urothelial Carcinoma Understanding The ... Read More
-
Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Recurrent ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
... Diagnostics market in the 7 major pharmaceutical markets. The report also gives a brief competitive analysis of both the current and emerging products, to help understand the competition in the market. Liquid Biopsy for Cancer ... Read More
-
Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
B-Cell Non-Hodgkin Lymphoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 B-Cell Non-Hodgkin Lymphoma Understanding The ... Read More
-
Urothelial Carcinoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Urothelial Carcinoma Understanding The DelveInsight Urothelial Carcinoma ... Read More
-
Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Neuroendocrine Carcinoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Neuroendocrine Carcinoma Understanding The DelveInsight Neuroendocrine Carcinoma ... Read More
-
Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis
... the main aim of lung cancer screening is to detect lung cancer at its earliest and most treatable stage. Collectively, screening tests involve lab tests that monitor blood and other fluids, genetic tests that study ... Read More
-
Surgery and Radiation Therapy in Brain Cancer- Market Insight, Competive Landscape and Market Forecast- 2026
... understanding of Surgery and Radiation Therapy in Brain Cancer and the historical and forecasted Surgery and Radiation Therapy in Brain Cancer market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Surgery ... Read More
-
Checkpoint Inhibitor Refractory Cancer -Epidemiology Forecast 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Checkpoint Inhibitor Refractory ... Read More
-
HER2 Lung Cancer - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER2 Lung Cancer Understanding The ... Read More
-
Mycosis Fungoides - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Mycosis Fungoides Understanding The DelveInsight Mycosis Fungoides ... Read More
-
Laryngeal Cancer - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Laryngeal Cancer Understanding The DelveInsight Laryngeal Cancer ... Read More
-
Metastatic HER2 positive breast cancer - Market Insight, Epidemiology and Market Forecast -2032
... HER2 positive breast cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic HER2 positive breast cancer market report provides current treatment practices, emerging drugs, Metastatic ... Read More
-
Gliosarcoma - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gliosarcoma Understanding The DelveInsight Gliosarcoma epidemiology report gives a ... Read More
-
Uveal Melanoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Uveal Melanoma Understanding The DelveInsight Uveal Melanoma ... Read More
-
Advanced Renal Cell Carcinoma (RCC) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Advanced ... Read More
-
Ductal Carcinoma in Situ - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Ductal Carcinoma in ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Epidemiology Forecast - 2032
... epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) ... Read More
-
T-Cell Blood Cancer- Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 T-Cell Blood Cancer Understanding The ... Read More
Research Assistance
